Doximity climbs on upbeat annual forecast

** Shares of telehealth firm Doximity DOCS rise 8.7% to $63.74 premarket

** Late on Thursday, company raised FY26 sales forecast to between $628 mln and $636 mln, from $619 mln and $631 mln projected earlier

** Analysts estimate FY26 sales at be $628 mln - data compiled by LSEG

** Q1 sales of $145.9 mln above estimate of $139.5 mln

** Q1 adjusted EPS of 36 cents compares with estimate of 30 cents

** Separately, Doximity acquires Montreal-based Pathway Medical, an AI-driven clinical reference startup, for up to $63 mln

** As of last close, stock up 9.6% YTD